Trial Profile
Timing of adjunctive trastuzumab therapy influence overall survival in HER2+ early stage breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 11 May 2015 New trial record